Constellium SE (CSTM)
Last Price$11.83.7%
Market Cap$1,676.1M
CSTM Rating
CSTM Quality rating performance
CSTM Intrinsic Value
Key Highlights:
As of Mar 11, 2025 CSTM Relative Value is $37.0, which is undervalued by 212.4%, compared to current share price of $11.8.
As of Mar 11, 2025 CSTM DCF Value is ($10.9), which is overvalued by 192.1%, compared to current share price of $11.8.
CSTM Share Price History
1W 16.3%
1M 25.1%
6M (27.9%)
YTD (39.6%)
1Y (41.4%)
3Y (32.6%)
5Y 58.8%
10Y (37.4%)
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
CSTM Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$1,676.1M
$3,547.9M
€7,080.5M
(€108.1M)
Shares Outstanding
142M
Employees
12K
Growth (CAGR)
3.7%
16.9%
(3.29%)
166.84%
Profitability
12.8%
7.9%
4.1%
(1.5%)
(199.7%)
Intrinsic Value
$38.2 (222.6% undervalued)
($11.3)
$38.2
(100.0%)
143.0%
Valuation (LTM)
Return on Capital
Financial Health
€1,715.3M
(15.9x)
263.8%
Dividends
Earnings
Jul 21, 2025
BEAT by 3.6%
MISS by 137.0%
(440.0%)
2 Beat & 8 Miss
CSTM Stock Financials
CSTM Income Statement Metrics
Annual
Quarterly
LTM
CSTM Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$314.3M -41.6% YoY
Capital Expenditure (CAPEX)
($431.3M) +20.4% YoY
Free Cash Flow (FCF)
($117.0M) N/A YoY
CSTM Income Statement Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$7,659.7M (2.2%) YoY
Cost of revenue
$6,680.2M (5.4%) YoY
Pre-tax income
$141.0M (33.5%) YoY
1.8% margin
CSTM Balance Sheet Overview
Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$4,902.0M
Current assets ($1,899.1M, 38.7% of total)
$146.0M (3.0%)
$503.2M (10.3%)
Other current assets
$1,249.8M (25.5%)
Non-current assets ($3,002.9M, 61.3% of total)
$0.0 (0.0%)
$2,493.5M (50.9%)
$100.4M (2.0%)
Other non-current assets
$409.0M (8.3%)
Financial position
$1,772.6M
Cash & Short-term
Investments
Total Debt
CSTM Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
CSTM Earnings Surprises
Crunching data... Almost there!
CSTM Dividends
CSTM Dividend Yield
Crunching data... Almost there!
CSTM Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with CSTM
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$1,676.1M | 5.4 | $38.2 222.6% undervalued | (41.4%) | €7,080.5M | (€108.1M) | (1.6%) | (1.5%) | 12.8% | 16.9% | 263.8% | |
$50.1B | 7.2 | $54.6 45.8% overvalued | 84.4% | $8,294.5M | $2,123.7M | 24.3% | 25.6% | 43.3% | 4.9% | 6.2% | |
$9,940.6M | 7.1 | $17.3 27.6% overvalued | 75.1% | $1,345.6M | $234.2M | 30.6% | 17.4% | 43.3% | 7.4% | 8.0% | |
$8,579.9M | 5.3 | $129.6 78.4% undervalued | (40.8%) | $5,377.5M | ($983.7M) | (44.1%) | (18.3%) | 1.1% | (12.0%) | 34.5% | |
$8,202.8M | 5.7 | $124.0 288.1% undervalued | 6.0% | $11.9B | $42.0M | 12.7% | 0.4% | 15.6% | 4.5% | 49.3% | |
$1,791.0M | 4.7 | $8.2 33.8% undervalued | 12.9% | $529.4M | ($21.6M) | (9.9%) | (4.1%) | 10.6% | (4.2%) | 16.9% | |
$1,682.4M | 6.2 | $27.7 52.8% undervalued | 57.9% | $2,220.3M | ($106.9M) | 1.6% | (4.8%) | 8.3% | 8.0% | 78.2% | |
$1,072.5M | 5.1 | $108.9 60.5% undervalued | (8.1%) | $3,024.0M | ($13.7M) | (2.0%) | (0.5%) | 8.1% | 4.2% | 161.0% | |
$115.3M | 5.2 | $13.5 16.0% undervalued | 10.8% | $144.5M | $14.4M | (30.6%) | 10.0% | 15.3% | (9.6%) | 35.2% | |
$101.5M | 4.5 | $23.7 1,591.5% undervalued | (36.9%) | $965.3M | ($3,519.0K) | (21.1%) | (0.4%) | 1.1% | (35.6%) | (2.8%) |
FAQ
What is Constellium SE (CSTM) stock rating?
As of today, Constellium SE has a stock rating of 5 (out of 10), which is considered Good.
is Constellium SE (CSTM) a good stock to buy?
As of today, Constellium SE has a Good stock rating, which is 222.6% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.